Integrated Medtech Platform Velosity recently expanded to acquire Lucid Labs and integrate product design, engineering, and precision manufacturing capabilities, signaling a strategic move toward a comprehensive end-to-end solution for medical device OEMs that could appeal to customers seeking streamlined development-to-production partnerships.

Engineering Talent Growth The acquisition of Lucid Labs brings over 20 design and development engineers and elevates Velosity's R&D capabilities, enabling them to offer stronger design-for-manufacturing and faster time-to-market services to new and existing OEM customers.

Innovation Lab Investment Velosity’s multi‑million-dollar Velosity Lab and a 5,000-ft² innovation facility in Minnesota indicate a commitment to advanced machining development and prototyping, presenting opportunities to attract customers requiring rapid iteration, validation, and performance improvements.

Safety & Reliability Recognized with Minnesota safety awards and a strong incident-rate performance, Velosity positions itself as a reliable, quality-focused partner, which can be a differentiator in highly regulated medical device programs and a basis for pursuing new safety-critical component manufacturing contracts.

Regional Manufacturing Reach Strategic presence in Minnesota with a sizable machining center and design capabilities enables Velosity to target nearby medical device OEMs for co‑location or near‑shore partnerships, reducing lead times and logistics costs for customers seeking agile, regionally located contract manufacturing.